Hélène Merle‐Béral

9.0k citations

157 papers · 4.3k indexed · h-index 37

Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 93
Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment 67
Immunology top 1%
- Immunodeficiency and Autoimmune Disorders 33
- Immune Cell Function and Interaction 13
Neurology top 2%
- CNS Lymphoma Diagnosis and Treatment 19
Hematology top 2%
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 15
Oncology
- Cancer-related Molecular Pathways 11
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 11

Co-authors: Patrice Debré Frédéric Davi Jozo Delić Nathalie Cassoux Phuc LeHoang Bahram Bodaghi Karim Maloum Magali Le Garff‐Tavernier
Cited by: Genetics Pathology and Forensic Medicine Immunology
Journals: Journal of Clinical Investigation (1 paper)The Journal of Experimental Medicine (1 paper)Journal of Clinical Oncology (2 papers)
Partner nations: France Canada United States

In The Last Decade

Hélène Merle‐Béral

150 papers receiving 4.2k citations

Peers

Countries citing papers authored by Hélène Merle‐Béral

Since Specialization

Citations

This map shows the geographic impact of Hélène Merle‐Béral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Merle‐Béral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Merle‐Béral more than expected).

Fields of papers citing papers by Hélène Merle‐Béral

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Merle‐Béral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Merle‐Béral. The network helps show where Hélène Merle‐Béral may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hélène Merle‐Béral, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hélène Merle‐Béral Line = papers co-authored together Hélène Merle‐Béral links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia Leukemia ·Mariana Tannoury,Marianne Ayoub,Léa Dehgane,Ivan Nemazanyy,Kenza Dubois,Charlotte Izabelle,Aurélie Brousse,Damien Roos‐Weil,Karim Maloum,Hélène Merle‐Béral,Brigitte Bauvois,Bruno Saubaméa,Élise Chapiro,Florence Nguyen‐Khac,Delphine Garnier,Santos A. Susín	2023	11
2	Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire Blood Advances ·Nabila Belhouachi,Aliki Xochelli,Myriam Boudjoghra,Claude Lesty,Nathalie Cassoux,Christine Fardeau,Thi Hà Châu Tran,Sylvain Choquet,Bishnu Sarker,Caroline Houillier,Agustí Alentorn,Phuc LeHoang,Carole Soussain,Valérie Touitou,Hélène Merle‐Béral,Khê Hoang‐Xuan,Bahram Bodaghi,Κώστας Σταματόπουλος,Frédéric Davi	2020	25
3	Targeting chronic lymphocytic leukemia with N-methylated thrombospondin-1–derived peptides overcomes drug resistance Blood Advances ·Élodie Pramil,Linda Herbi Bastian,Thomas Denèfle,Fariba Némati,Malina Xiao,Eva Lardé,Karim Maloum,Damien Roos‐Weil,Élise Chapiro,Magali Le Garff‐Tavernier,Frédéric Davi,Didier Decaudin,Marika Sarfati,Florence Nguyen‐Khac,Hélène Merle‐Béral,Philippe Karoyan,Santos A. Susín	2019	9
4	Cerebrospinal fluid interleukin (IL)-10 and IL-10:IL-6 ratio as biomarkers for small B-cell lymphoproliferations with leptomeningeal dissemination Seminars in Hematology ·Myrto Costopoulos,Rathana Kim,Sylvain Choquet,Karim Maloum,Caroline Houillier,Caroline Algrin,Catherine Settegrana,Juliette Villemonteix,Martine Brissard,Claire Quiney,Sophie Bernard,Frédéric Davi,Catherine Thiéblemont,Khê Hoang‐Xuan,Véronique Leblond,Hélène Merle‐Béral,Magali Le Garff‐Tavernier	2017	5
5	More Than a Masquerade Syndrome: Atypical Presentations of Vitreoretinal Lymphomas Ocular Immunology and Inflammation ·Abdullah Alqahtani,Valérie Touitou,Nathalie Cassoux,C. Aknin,Hélène Merle‐Béral,Bahram Bodaghi,Phuc LeHoang	2014	26
6	Cytokine Profile in Human Eyes: Contribution of a New Cytokine Combination for Differential Diagnosis between Intraocular Lymphoma or Uveitis PLoS ONE ·Sylvain Fisson,Hanane Ouakrim,Valérie Touitou,Sylvie Baudet,Rym Ben Abdelwahed,Sabrina Donnou,Amine Miloudi,C Galand,Bahram Bodaghi,Phuc LeHoang,Martine Brissard,Magali Le Garff‐Tavernier,Wolf H. Fridman,Catherine Sautès‐Fridman,Nathalie Cassoux,Hélène Merle‐Béral	2013	57
7	Waldenström’s macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disorders Blood Cancer Journal ·Aurore Perrot,Cédric Pionneau,Nabih Azar,Claude Baillou,F M Lemoine,V Leblond,Hélène Merle‐Béral,M-C Béné,Raoul Herbrecht,Seiamak Bahram,Laurent Vallat	2012	5
8	Human NK cells display major phenotypic and functional changes over the life span Aging Cell ·Magali Le Garff‐Tavernier,Vivien Béziat,Julie Decocq,Virginie Siguret,Frédérique Gandjbakhch,Éric Pautas,Patrice Debré,Hélène Merle‐Béral,Vincent Vieillard	2010	247
9	Concomitant heterochromatinisation and down-regulation of gene expression unveils epigenetic silencing of RELBin an aggressive subset of chronic lymphocytic leukemia in males BMC Medical Genomics ·Jean‐Brice Marteau,O. Rigaud,Thibaut Brugat,Nathalie Gault,Laurent Vallat,Mogens Kruhøffer,Torben F. Ørntoft,Florence Nguyen‐Khac,Sylvie Chevillard,Hélène Merle‐Béral,Jozo Delić	2010	11
10	Caspase-independent type III programmed cell death in chronic lymphocytic leukemia: the key role of the F-actin cytoskeleton Haematologica ·Sandrine Barbier,Laurent Châtre,Morgane Le Bras,Patricia Sancho,Gaël Roué,Clémence Virely,Vı́ctor J. Yuste,Sylvie Baudet,Manuel Rubio,Josep E. Esquerda,Marika Sarfati,Hélène Merle‐Béral,Santos A. Susín	2009	21
11	IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide Annals of Hematology ·Karim Maloum,Catherine Settegrana,Élise Chapiro,Bruno Cazin,Stéphane Leprêtre,Alain Delmer,M Leporrier,Brigitte Dreyfus,Olivier Tournilhac,Beatrice Mahé,Florence Nguyen‐Khac,Claude Lesty,Frédéric Davi,Hélène Merle‐Béral	2009	23
12	Transcriptional activation of the cardiac homeobox gene CSX1/NKX2-5 in a B-cell chronic lymphoproliferative disorder Haematologica ·Xin Su,Véronique Della-Valle,Éric Delabesse,Zahia Azgui,Roland Berger,Hélène Merle‐Béral,Olivier Bernard,Florence Nguyen‐Khac	2008	6
13	Natural Phosphorylation of CD5 in Chronic Lymphocytic Leukemia B Cells and Analysis of CD5-Regulated Genes in a B Cell Line Suggest a Role for CD5 in Malignant Phenotype The Journal of Immunology ·Hélène Gary‐Gouy,Alexander Sainz‐Perez,Jean‐Brice Marteau,Anne Marfaing‐Koka,Jozo Delić,Hélène Merle‐Béral,Pierre Galanaud,Ali Dalloul	2007	42
14	Ubiquitin-Proteasome System and Increased Sensitivity of B-CLL Lymphocytes to Apoptotic Death Activation Leukemia & lymphoma ·Peggy Masdehors,Hélène Merle‐Béral,H Magdelénat,Jozo Delić	2000	40
15	AIDS-Related Primary Lymphoma of the Pleural Cavity Acta Cytologica ·George Mansour,Frédéric Charlotte,Vincent Cálvez,Frédéric Davi,Hélène Merle‐Béral	1998	6
16	Uvéite: complication tardive d'une maladie de Whipple méconnue La Revue de Médecine Interne ·B. Wechsler,R Fior,Isabelle Reux,N Cassou,P. Le Hoang,Hélène Merle‐Béral,Jean Marc Ziza,P Godeau	1995	4
17	Interleukin-7 is a growth factor for Sézary lymphoma cells. Journal of Clinical Investigation ·AH Dalloul,L. Laroche,Martine Bagot,M. Djavad Mossalayi,C. R. Fourcade,D J Thacker,Donna E. Hogge,Hélène Merle‐Béral,Patrice Debré,(unknown)	1992	133
18	B8.7 Antigen expression on B-CLL cells and its relationship to the LMW-BCGF responsiveness Leukemia Research ·Saoussen Karray,Corinne Leprince,Hélène Merle‐Béral,Patrice Debré,Yolande Richard,Pierre Galanaud	1990	2
19	Positive effects of interferon-alpha on B cell-type chronic lymphocytic leukemia proliferative response. The Journal of Immunology ·Saoussen Karray,J F Delfraissy,Hélène Merle‐Béral,Christine Wallon,Patrice Debré,Pierre Galanaud	1988	31
20	Phenotypic heterogeneity of B‐ and T‐cell differentiation antigens in B‐CLL European Journal Of Haematology ·Hélène Merle‐Béral,Catherine Blanc,Claude Chastang,Patrice Debré	1988	8

About Hélène Merle‐Béral

Hélène Merle‐Béral is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology, having authored 157 papers that have together received 4.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (93 papers), Lymphoma Diagnosis and Treatment (67 papers), Immunodeficiency and Autoimmune Disorders (33 papers), CNS Lymphoma Diagnosis and Treatment (19 papers), Acute Lymphoblastic Leukemia research (15 papers), Immune Cell Function and Interaction (13 papers), Cancer-related Molecular Pathways (11 papers) and Monoclonal and Polyclonal Antibodies Research (11 papers). The work is most often cited by research in Genetics (1.6k citations), Pathology and Forensic Medicine (1.6k citations) and Immunology (1.7k citations). Hélène Merle‐Béral has collaborated with scholars based in France, Canada and United States. Frequent co-authors include Patrice Debré, Frédéric Davi, Jozo Delić, Nathalie Cassoux, Phuc LeHoang, Bahram Bodaghi, Karim Maloum, Magali Le Garff‐Tavernier, Sylvie Baudet and Saoussen Karray. Their work appears in journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact